2
RESEARCH METHODOLOGY
35
5
MARKET OVERVIEW
Explosive growth in digital health solutions revolutionizes diabetes care with patient-centric innovations.
56
5.2.1.1
Surging global diabetes patient population requiring continuous care
5.2.1.2
Rapidly growing geriatric population
5.2.1.3
Increasing efforts toward public awareness and preventive healthcare
5.2.1.4
Rapid technological advancements in diabetes care
5.2.2.1
High cost of advanced diabetes care devices
5.2.2.2
Limited awareness in emerging healthcare markets
5.2.3.1
Enhanced diabetes management with advanced patient-implantable continuous glucose monitoring devices
5.2.4.1
Limited sensor durability with repeated and costly replacements
5.2.4.2
High cost and socio-economic disparities in access to diabetes care devices
5.3.1
RISING ADOPTION OF DIGITAL HEALTH SOLUTIONS AND TELEMEDICINE INTEGRATION IN DIABETES CARE
5.3.2
ACCELERATING SHIFT TOWARD HOME-BASED, PATIENT-CENTRIC, AND SELF-MANAGED DIABETES CARE
5.4.1.1
Implantable sensors
5.4.1.2
Smart automated insulin pumps
5.4.2
COMPLEMENTARY TECHNOLOGIES
5.4.2.1
Telehealth services
5.4.3
ADJACENT TECHNOLOGIES
5.4.3.1
Cutting-edge and smartphone-enabled diabetes self-management technologies
5.5.1
AVERAGE SELLING PRICE TREND OF DIABETES CARE DEVICES, BY KEY PLAYER, 2022–2024
5.5.2
AVERAGE SELLING PRICE TREND OF DIABETES CARE DEVICES, BY REGION, 2022–2024
5.7
REIMBURSEMENT SCENARIO ANALYSIS
5.9
PORTER’S FIVE FORCES ANALYSIS
5.9.1
INTENSITY OF COMPETITIVE RIVALRY
5.9.2
BARGAINING POWER OF SUPPLIERS
5.9.3
BARGAINING POWER OF BUYERS
5.9.4
THREAT OF SUBSTITUTES
5.9.5
THREAT OF NEW ENTRANTS
5.10
KEY STAKEHOLDERS & BUYING CRITERIA
5.10.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.10.2
KEY BUYING CRITERIA
5.11.1
IMPORT DATA FOR HS CODE 9027, 2020–2024
5.11.2
EXPORT DATA FOR HS CODE 9027, 2020–2024
5.12.1
REGULATORY FRAMEWORK
5.12.2
REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.13.1
PATENT PUBLICATION TRENDS FOR DIABETES CARE DEVICES MARKET
5.13.2
JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN DIABETES CARE DEVICES
5.13.3
LIST OF MAJOR PATENTS
5.14
KEY CONFERENCES & EVENTS, 2025–2026
5.15
ADJACENT MARKET ANALYSIS
5.16
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.17
UNMET NEEDS/END-USER EXPECTATIONS
5.17.2
END-USER EXPECTATIONS
5.18
IMPACT OF AI/GEN AI IN DIABETES CARE DEVICES MARKET
5.19.1
LONG-TERM GLUCOSE MONITORING FOR SENSITIVE SKIN PATIENTS USING SENSEONICS’ EVERSENSE E3 IMPLANTABLE SENSORS
5.19.2
ENHANCING PATIENT ADHERENCE AND GLYCEMIC CONTROL USING ABBOTT’S FREESTYLE LIBRE 2 CGM
5.19.3
MEDTRONIC MINIMED INSULIN PUMP TO ENHANCE GLUCOSE CONTROL AND IMPROVE DAILY MANAGEMENT FOR PEOPLE WITH DIABETES
5.20
INVESTMENT & FUNDING SCENARIO
5.21
IMPACT OF 2025 US TARIFF ON DIABETES CARE DEVICES MARKET
5.21.3
PRICE IMPACT ANALYSIS
5.21.4
IMPACT ON END-USE INDUSTRIES
6
DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 23 Data Tables
88
6.2
BLOOD GLUCOSE MONITORING SYSTEMS
6.2.1
SELF-MONITORING BLOOD GLUCOSE SYSTEMS
6.2.1.1
Need for self-monitoring in type 1 and type 2 diabetes management to propel market growth
6.2.2
CONTINUOUS GLUCOSE MONITORING SYSTEMS
6.2.2.1
Technological advancements in continuous glucose monitoring systems to track trends and enhance diabetes management
6.2.3
TEST STRIPS/TEST PAPERS
6.2.3.1
Shift toward non-invasive methods for blood glucose monitoring to restrain market growth
6.2.4
LANCETS/LANCING DEVICES
6.2.4.1
Need for infection and accidental pricking to increase popularity of safety lancets/lancing devices
6.3
INSULIN DELIVERY DEVICES
6.3.1
INSULIN PUMPS & ACCESSORIES
6.3.1.2
Tubeless insulin pumps
6.3.2.1
Reusable insulin pens
6.3.2.2
Disposable insulin pens
6.3.3.1
Reduced chances of infection and accidental pricking to augment market growth
6.3.4
INSULIN SYRINGES & NEEDLES
6.3.4.1
Safety concerns and need for affordable alternatives to limit market growth
6.3.5
OTHER INSULIN DELIVERY DEVICES
6.4
DIABETES MANAGEMENT MOBILE APPLICATIONS
6.4.1
INCREASING PREVALENCE OF DIABETES AND RISING ADOPTION OF BLOOD GLUCOSE TRACKING APPLICATIONS TO DRIVE MARKET
7
DIABETES CARE DEVICES MARKET, BY DISEASE TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 3 Data Tables
115
7.2.1
CHRONIC NATURE OF TYPE 1 DIABETES AND NEED FOR IMPROVED DIAGNOSIS TO AID MARKET GROWTH
7.3.1
RISING BURDEN OF TYPE 2 DIABETES TO INCREASE NEED FOR SCALABLE CARE DEVICE SOLUTIONS
8
DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 3 Data Tables
120
8.2.1
INCREASING AFFORDABILITY OF SELF-MONITORING SYSTEMS AND INSULIN DELIVERY DEVICES TO FUEL PREFERENCE
8.3
HOSPITALS & DIABETES SPECIALTY CLINICS
8.3.1
RISING DEMAND FOR POINT-OF-CARE TESTING IN HOSPITALS TO BOOST MARKET GROWTH
9
DIABETES CARE DEVICES MARKET, BY REGION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 166 Data Tables
126
9.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2.1
US to dominate North American diabetes care devices market during forecast period
9.2.3.1
High prevalence of diabetes and supportive government disease management initiatives to spur market growth
9.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2.1
Advanced healthcare infrastructure to drive adoption of innovative diabetes care devices
9.3.3.1
Increased government support and improved research funding to propel market growth
9.3.4.1
Substantial national spending on diabetes management and robust healthcare infrastructure to aid market growth
9.3.5.1
High diabetes-related mortality and increased public investment to augment market growth
9.3.6.1
Minimal co-payments and full reimbursement to drive market
9.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2.1
Huge diabetic population and high government healthcare spending to spur market growth
9.4.3.1
Increased geriatric population and supportive healthcare policies to support market growth
9.4.4.1
Rise in diabetes cases and affordable local manufacturing to fuel diabetes care devices demand
9.4.5.1
Comprehensive government-backed initiatives and subsidies to support market growth
9.4.6.1
Rise in diabetes cases and strong government healthcare support to boost market growth
9.4.7
REST OF ASIA PACIFIC
9.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2.1
Increasing adoption of advanced diabetes monitoring and management solutions to aid market growth
9.5.3.1
Supportive regulatory frameworks and high burden of diabetes to propel market growth
9.5.4
REST OF LATIN AMERICA
9.6.1
INCREASING AWARENESS OF EARLY DIAGNOSIS AND GLYCEMIC CONTROL FOR DIABETES MANAGEMENT TO FAVOR MARKET GROWTH
9.6.2
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.7.1
RISE IN DIABETES PREVALENCE AND HIGH PER CAPITA HEALTHCARE EXPENDITURE TO DRIVE MARKET
9.7.2
MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
10
COMPETITIVE LANDSCAPE
Discover strategic dominance and emerging leaders shaping the diabetes care devices market landscape.
201
10.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN DIABETES CARE DEVICES MARKET
10.3
REVENUE ANALYSIS, 2020–2024
10.4
MARKET SHARE ANALYSIS, 2024
10.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
10.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
10.5.5.1
Company footprint
10.5.5.2
Region footprint
10.5.5.3
Product type footprint
10.5.5.4
Patient care settings footprint
10.5.5.5
Disease type footprint
10.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
10.6.1
PROGRESSIVE COMPANIES
10.6.2
RESPONSIVE COMPANIES
10.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
10.6.5.1
Detailed list of key startups/SMEs
10.6.5.2
Competitive benchmarking of key startups/SMEs
10.7
COMPANY VALUATION & FINANCIAL METRICS
10.8
BRAND/PRODUCT COMPARISON
10.9
R&D EXPENDITURE OF KEY PLAYERS
10.10
COMPETITIVE SCENARIO
10.10.1
PRODUCT LAUNCHES AND APPROVALS
10.10.4
OTHER DEVELOPMENTS
11
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
221
11.1.1
F. HOFFMAN-LA ROCHE LTD.
11.1.1.1
Business overview
11.1.1.2
Products/Solutions offered
11.1.1.3
Recent developments
11.1.11
TANDEM DIABETES CARE, INC.
11.1.12
INSULET CORPORATION
11.1.13
ACON LABORATORIES, INC.
11.1.15
TERUMO CORPORATION
11.2.3
LIFESCAN IP HOLDINGS, LLC
11.2.4
SD BIOSENSOR, INC.
11.2.6
SUNGSHIM MEDICAL CO., LTD.
11.2.7
SOOIL DEVELOPMENTS CO., LTD.
11.2.8
HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.
11.2.9
MICROGENE DIAGNOSTIC SYSTEMS (P) LTD.
11.2.10
ROSSMAX INTERNATIONAL LTD.
12.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3
CUSTOMIZATION OPTIONS
TABLE 1
DIABETES CARE DEVICES MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2
STANDARD CURRENCY CONVERSION RATES
TABLE 3
STUDY ASSUMPTIONS IN DIABETES CARE DEVICES MARKET
TABLE 4
RISK ANALYSIS IN DIABETES CARE DEVICES MARKET
TABLE 5
AVERAGE SELLING PRICE TREND OF DIABETES CARE DEVICES, BY KEY PLAYER, 2022–2024 (USD)
TABLE 6
AVERAGE SELLING PRICE TREND OF DIABETES CARE, BY REGION, 2022–2024 (USD)
TABLE 7
DIABETES CARE DEVICES MARKET: ROLE IN ECOSYSTEM
TABLE 8
DIABETES CARE DEVICES MARKET: PORTER’S FIVE FORCES
TABLE 9
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER
TABLE 10
KEY BUYING CRITERIA FOR MAJOR END USERS
TABLE 11
IMPORT DATA FOR HS CODE 9027, BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 12
EXPORT DATA FOR HS CODE 9027, BY COUNTRY, 2020–2024 (USD THOUSAND)
TABLE 13
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 15
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 16
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18
LIST OF MAJOR PATENTS IN DIABETES CARE DEVICES MARKET, 2022–2024
TABLE 19
DIABETES CARE DEVICES MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
TABLE 20
UNMET NEEDS IN DIABETES CARE DEVICES MARKET
TABLE 21
END-USER EXPECTATIONS IN DIABETES CARE DEVICES MARKET
TABLE 22
IMPACT OF AI/GEN AI IN DIABETES CARE DEVICES MARKET
TABLE 23
CASE STUDY 1: LONG-TERM GLUCOSE MONITORING FOR SENSITIVE SKIN PATIENTS USING SENSEONICS’ EVERSENSE E3 IMPLANTABLE SENSORS
TABLE 24
CASE STUDY 2: ENHANCING PATIENT ADHERENCE AND GLYCEMIC CONTROL USING ABBOTT’S FREESTYLE LIBRE 2 CGM
TABLE 25
CASE STUDY 3: MEDTRONIC MINIMED INSULIN PUMP TO ENHANCE GLUCOSE CONTROL AND IMPROVE DAILY MANAGEMENT FOR PEOPLE WITH DIABETES
TABLE 26
US-ADJUSTED RECIPROCAL TARIFF RATES
TABLE 27
DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 28
DIABETES CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 29
DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 30
DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 31
SELF-MONITORING BLOOD GLUCOSE SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 32
CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 33
TEST STRIPS/TEST PAPERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 34
LANCETS/LANCING DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 35
DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 36
DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 37
INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 38
INSULIN PUMPS & ACCESSORIES MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
TABLE 39
INSULIN PUMPS & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 40
TETHERED INSULIN PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 41
TUBELESS INSULIN PUMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 42
INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 43
INSULIN PENS MARKET, COUNTRY, 2023–2030 (USD MILLION)
TABLE 44
REUSABLE INSULIN PENS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 45
DISPOSABLE INSULIN PENS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 46
PEN NEEDLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 47
INSULIN SYRINGES & NEEDLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 48
OTHER INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49
DIABETES CARE DEVICES MARKET FOR DIABETES MANAGEMENT MOBILE APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 50
DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 51
TYPE 1 DIABETES CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 52
TYPE 2 DIABETES CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 53
DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 54
DIABETES CARE DEVICES MARKET FOR SELF/HOME HEALTHCARE, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 55
DIABETES CARE DEVICES MARKET FOR HOSPITAL & DIABETES SPECIALTY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 56
DIABETES CARE DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 57
NORTH AMERICA: DIABETES CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 58
NORTH AMERICA: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 59
NORTH AMERICA: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 60
NORTH AMERICA: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 61
NORTH AMERICA: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 62
NORTH AMERICA: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 63
NORTH AMERICA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 64
NORTH AMERICA: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 65
US: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 66
US: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 67
US: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 68
US: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 69
US: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 70
US: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 71
US: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 72
CANADA: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 73
CANADA: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 74
CANADA: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 75
CANADA: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 76
CANADA: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 77
CANADA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 78
CANADA: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 79
EUROPE: DIABETES CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 80
EUROPE: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 81
EUROPE: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 82
EUROPE: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 83
EUROPE: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 84
EUROPE: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 85
EUROPE: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 86
EUROPE: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 87
GERMANY: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 88
GERMANY: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 89
GERMANY: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 90
GERMANY: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 91
GERMANY: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 92
GERMANY: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 93
GERMANY: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 94
UK: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 95
UK: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 96
UK: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 97
UK: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 98
UK: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 99
UK: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 100
UK: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 101
FRANCE: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 102
FRANCE: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 103
FRANCE: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 104
FRANCE: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 105
FRANCE: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 106
FRANCE: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 107
FRANCE: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 108
ITALY: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 109
ITALY: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 110
ITALY: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 111
ITALY: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 112
ITALY: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 113
ITALY: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 114
ITALY: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 115
SPAIN: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 116
SPAIN: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 117
SPAIN: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 118
SPAIN: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 119
SPAIN: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 120
SPAIN: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 121
SPAIN: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 122
REST OF EUROPE: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 123
REST OF EUROPE: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 124
REST OF EUROPE: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 125
REST OF EUROPE: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 126
REST OF EUROPE: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 127
REST OF EUROPE: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 128
REST OF EUROPE: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 129
ASIA PACIFIC: DIABETES CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 130
ASIA PACIFIC: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 131
ASIA PACIFIC: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 132
ASIA PACIFIC: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 133
ASIA PACIFIC: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 134
ASIA PACIFIC: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 135
ASIA PACIFIC: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 136
ASIA PACIFIC: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 137
CHINA: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 138
CHINA: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 139
CHINA: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 140
CHINA: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 141
CHINA: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 142
CHINA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 143
CHINA: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 144
JAPAN: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 145
JAPAN: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 146
JAPAN: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 147
JAPAN: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 148
JAPAN: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 149
JAPAN: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 150
JAPAN: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 151
INDIA: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 152
INDIA: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 153
INDIA: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 154
INDIA: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 155
INDIA: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 156
INDIA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 157
INDIA: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 158
AUSTRALIA: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 159
AUSTRALIA: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 160
AUSTRALIA: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 161
AUSTRALIA: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 162
AUSTRALIA: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 163
AUSTRALIA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 164
AUSTRALIA: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 165
SOUTH KOREA: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 166
SOUTH KOREA: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 167
SOUTH KOREA: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 168
SOUTH KOREA: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 169
SOUTH KOREA: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 170
SOUTH KOREA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 171
SOUTH KOREA: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 172
REST OF ASIA PACIFIC: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 173
REST OF ASIA PACIFIC: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 174
REST OF ASIA PACIFIC: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 175
REST OF ASIA PACIFIC: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 176
REST OF ASIA PACIFIC: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 177
REST OF ASIA PACIFIC: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 178
REST OF ASIA PACIFIC: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 179
LATIN AMERICA: DIABETES CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 180
LATIN AMERICA: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 181
LATIN AMERICA: DIABETES CARE DEVICES MARTKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 182
LATIN AMERICA: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 183
LATIN AMERICA: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 184
LATIN AMERICA: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 185
LATIN AMERICA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 186
LATIN AMERICA: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 187
BRAZIL: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 188
BRAZIL: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 189
BRAZIL: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 190
BRAZIL: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 191
BRAZIL: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 192
BRAZIL: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 193
BRAZIL: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 194
MEXICO: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 195
MEXICO: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 196
MEXICO: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 197
MEXICO: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 198
MEXICO: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 199
MEXICO: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 200
MEXICO: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 201
REST OF LATIN AMERICA: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 202
REST OF LATIN AMERICA: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 203
REST OF LATIN AMERICA: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 204
REST OF LATIN AMERICA: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 205
REST OF LATIN AMERICA: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 206
REST OF LATIN AMERICA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 207
REST OF LATIN AMERICA: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 208
MIDDLE EAST & AFRICA: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 209
MIDDLE EAST & AFRICA: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 210
MIDDLE EAST & AFRICA: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 211
MIDDLE EAST & AFRICA: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 212
MIDDLE EAST & AFRICA: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 213
MIDDLE EAST & AFRICA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 214
MIDDLE EAST & AFRICA: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 215
GCC COUNTRIES: DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION)
TABLE 216
GCC COUNTRIES: DIABETES CARE DEVICES MARKET FOR BLOOD GLUCOSE MONITORING SYSTEMS, BY TYPE, 2023–2030 (USD MILLION)
TABLE 217
GCC COUNTRIES: DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY TYPE, 2023–2030 (USD MILLION)
TABLE 218
GCC COUNTRIES: INSULIN PUMPS & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 219
GCC COUNTRIES: INSULIN PENS MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 220
GCC COUNTRIES: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2023–2030 (USD MILLION)
TABLE 221
GCC COUNTRIES: DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2023–2030 (USD MILLION)
TABLE 222
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN DIABETES CARE DEVICES MARKET, JANUARY 2022–AUGUST 2025
TABLE 223
DIABETES CARE DEVICES MARKET: DEGREE OF COMPETITION
TABLE 224
DIABETES CARE DEVICES MARKET: REGION FOOTPRINT
TABLE 225
DIABETES CARE DEVICES MARKET: PRODUCT TYPE FOOTPRINT
TABLE 226
DIABETES CARE DEVICES MARKET: PATIENT CARE SETTINGS FOOTPRINT
TABLE 227
DIABETES CARE DEVICES MARKET: DISEASE TYPE FOOTPRINT
TABLE 228
DIABETES CARE DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
TABLE 229
DIABETES CARE DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY PRODUCT TYPE AND REGION
TABLE 230
DIABETES CARE DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022– JUNE 2025
TABLE 231
DIABETES CARE DEVICES MARKET: DEALS, JANUARY 2022– JUNE 2025
TABLE 232
DIABETES CARE DEVICES MARKET: EXPANSIONS, JANUARY 2022– JUNE 2025
TABLE 233
DIABETES CARE DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2022– JUNE 2025
TABLE 234
F. HOFFMAN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 235
F. HOFFMAN-LA ROCHE LTD.: PRODUCTS/SOLUTIONS OFFERED
TABLE 236
F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 237
F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2022–AUGUST 2025
TABLE 238
F. HOFFMANN-LA ROCHE LTD.: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 239
ABBOTT: COMPANY OVERVIEW
TABLE 240
ABBOTT: PRODUCTS/SOLUTIONS OFFERED
TABLE 241
ABBOTT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 242
ABBOTT: DEALS, JANUARY 2022–AUGUST 2025
TABLE 243
ABBOTT: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 244
ABBOTT: OTHER DEVELOPMENTS, JANUARY 2022–AUGUST 2025
TABLE 245
DEXCOM, INC.: COMPANY OVERVIEW
TABLE 246
DEXCOM, INC.: PRODUCTS/SOLUTIONS OFFERED
TABLE 247
DEXCOM, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 248
DEXCOM, INC.: DEALS, JANUARY 2022–AUGUST 2025
TABLE 249
DEXCOM, INC.: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 250
MEDTRONIC: COMPANY OVERVIEW
TABLE 251
MEDTRONIC: PRODUCTS/SOLUTIONS OFFERED
TABLE 252
MEDTRONIC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 253
MEDTRONIC: DEALS, JANUARY 2022–AUGUST 2025
TABLE 254
MEDTRONIC: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 255
MEDTRONIC: OTHER DEVELOPMENTS, JANUARY 2022–AUGUST 2025
TABLE 256
B. BRAUN SE: COMPANY OVERVIEW
TABLE 257
B. BRAUN SE: PRODUCTS/SOLUTIONS OFFERED
TABLE 258
EMBECTA CORP.: COMPANY OVERVIEW
TABLE 259
EMBECTA CORP.: PRODUCTS/SOLUTIONS OFFERED
TABLE 260
EMBECTA CORP.: PRODUCTS APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 261
EMBECTA CORP.: DEALS, JANUARY 2022–AUGUST 2025
TABLE 262
EMBECTA CORP.: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 263
EMBECTA CORP.: OTHER DEVELOPMENTS, JANUARY 2022–AUGUST 2025
TABLE 264
NIPRO: COMPANY OVERVIEW
TABLE 265
NIPRO: PRODUCTS/SOLUTIONS OFFERED
TABLE 266
NIPRO: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 267
SENSEONICS: COMPANY OVERVIEW
TABLE 268
SENSEONICS: PRODUCTS/SOLUTIONS OFFERED
TABLE 269
SENSEONICS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 270
SENSEONICS: DEALS, JANUARY 2022–AUGUST 2025
TABLE 271
SENSEONICS: OTHER DEVELOPMENTS, JANUARY 2022–AUGUST 2025
TABLE 272
YPSOMED: COMPANY OVERVIEW
TABLE 273
YPSOMED: PRODUCTS/SOLUTIONS OFFERED
TABLE 274
YPSOMED: PRODUCTS LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 275
YPSOMED: DEALS, JANUARY 2022–AUGUST 2025
TABLE 276
YPSOMED: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 277
YPSOMED: OTHER DEVELOPMENTS, JANUARY 2022–AUGUST 2025
TABLE 278
I-SENS, INC.: COMPANY OVERVIEW
TABLE 279
I-SENS, INC.: PRODUCTS/SOLUTIONS OFFERED
TABLE 280
I-SENS, INC.: PRODUCTS APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 281
I-SENS, INC.: DEALS, JANUARY 2022–AUGUST 2025
TABLE 282
TANDEM DIABETES CARE, INC.: COMPANY OVERVIEW
TABLE 283
TANDEM DIABETES CARE, INC.: PRODUCTS/SOLUTIONS OFFERED
TABLE 284
TANDEM DIABETES CARE, INC.: PRODUCTS LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 285
TANDEM DIABETES CARE, INC.: DEALS, JANUARY 2022–AUGUST 2025
TABLE 286
INSULET CORPORATION: COMPANY OVERVIEW
TABLE 287
INSULET CORPORATION: PRODUCTS/SOLUTIONS OFFERED
TABLE 288
INSULET CORPORATION: PRODUCTS LAUNCHES & APPROVALS, JANUARY 2022–AUGUST 2025
TABLE 289
INSULET CORPORATION: DEALS, JANUARY 2022–AUGUST 2025
TABLE 290
INSULET CORPORATION: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 291
INSULET CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–AUGUST 2025
TABLE 292
ACON LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 293
ACON LABORATORIES, INC.: PRODUCTS/SOLUTIONS OFFERED
TABLE 294
ARKRAY, INC.: COMPANY OVERVIEW
TABLE 295
ARKRAY, INC.: PRODUCTS/SOLUTIONS OFFERED
TABLE 296
ARKRAY, INC.: PRODUCTS LAUNCHES, JANUARY 2022–AUGUST 2025
TABLE 297
TERUMO CORPORATION: COMPANY OVERVIEW
TABLE 298
TERUMO CORPORATION: PRODUCTS/SOLUTIONS OFFERED
TABLE 299
TERUMO CORPORATION: PRODUCTS LAUNCHES, JANUARY 2022–AUGUST 2025
TABLE 300
TERUMO CORPORATION: DEALS, JANUARY 2022–AUGUST 2025
TABLE 301
TERUMO CORPORATION: EXPANSIONS, JANUARY 2022–AUGUST 2025
TABLE 302
TERUMO CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–AUGUST 2025
TABLE 303
SINOCARE: COMPANY OVERVIEW
TABLE 304
AGAMATRIX: COMPANY OVERVIEW
TABLE 305
LIFESCAN IP HOLDINGS, LLC: COMPANY OVERVIEW
TABLE 306
SD BIOSENSOR, INC.: COMPANY OVERVIEW
TABLE 307
DEBIOTECH S.A.: COMPANY OVERVIEW
TABLE 308
SUNGSHIM MEDICAL CO., LTD.: COMPANY OVERVIEW
TABLE 309
SOOIL DEVELOPMENTS CO., LTD.: COMPANY OVERVIEW
TABLE 310
HINDUSTAN SYRINGES & MEDICAL DEVICES LTD.: COMPANY OVERVIEW
TABLE 311
MICROGENE DIAGNOSTIC SYSTEMS (P) LTD.: COMPANY OVERVIEW
TABLE 312
ROSSMAX INTERNATIONAL LTD.: COMPANY OVERVIEW
FIGURE 1
DIABETES CARE DEVICES MARKET SEGMENTATION & REGIONAL SCOPE
FIGURE 2
DIABETES CARE DEVICES MARKET: YEARS CONSIDERED
FIGURE 3
DIABETES CARE DEVICES MARKET: RESEARCH DESIGN
FIGURE 4
DIABETES CARE DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES
FIGURE 5
DIABETES CARE DEVICES MARKET: KEY PRIMARY SOURCES (SUPPLY AND DEMAND SIDES)
FIGURE 6
DIABETES CARE DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES
FIGURE 7
DIABETES CARE DEVICES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
FIGURE 8
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
FIGURE 9
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 10
DIABETES CARE DEVICES MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2024)
FIGURE 11
DIABETES CARE DEVICES MARKET: REVENUE SHARE ANALYSIS FOR ABBOTT (US) (2024)
FIGURE 12
SUPPLY-SIDE ANALYSIS OF DIABETES CARE DEVICES MARKET (2024)
FIGURE 13
DIABETES CARE DEVICES MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS)
FIGURE 14
DIABETES CARE DEVICES MARKET: BOTTOM-UP APPROACH
FIGURE 15
CAGR PROJECTIONS FROM DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS IN DIABETES CARE DEVICES MARKET (2025–2030)
FIGURE 16
DIABETES CARE DEVICES MARKET: TOP-DOWN APPROACH
FIGURE 17
DIABETES CARE DEVICES MARKET: DATA TRIANGULATION
FIGURE 18
DIABETES CARE DEVICES MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 19
DIABETES CARE DEVICES MARKET, BY DISEASE TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 20
DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2025 VS. 2030 (USD MILLION)
FIGURE 21
REGIONAL SNAPSHOT OF DIABETES CARE DEVICES MARKET
FIGURE 22
TECHNOLOGICAL ADVANCEMENTS IN DIABETES CARE DEVICES TO DRIVE MARKET
FIGURE 23
CHINA AND BLOOD GLUCOSE MONITORING SYSTEMS COMMNADED LARGEST ASIA PACIFIC MARKET SHARE IN 2024
FIGURE 24
JAPAN TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 25
ASIA PACIFIC TO REGISTER HIGHEST CAGR FROM 2025 TO 2030
FIGURE 26
EMERGING MARKETS TO ACCOUNT FOR HIGHER GROWTH RATES DURING STUDY PERIOD
FIGURE 27
DIABETES CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 28
DIABETES CARE DEVICES MARKET: ECOSYSTEM ANALYSIS
FIGURE 29
DIABETES CARE DEVICES MARKET: VALUE CHAIN ANALYSIS
FIGURE 30
DIABETES CARE DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 31
INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY END USER
FIGURE 32
KEY BUYING CRITERIA FOR MAJOR END USERS
FIGURE 33
TOP PATENT APPLICANTS/OWNERS (COMPANIES/INSTITUTES) FOR DIABETES CARE DEVICES MARKET (JANUARY 2014–DECEMBER 2024)
FIGURE 34
TOP PATENT APPLICANT COUNTRIES FOR PATENTS ON DIABETES CARE DEVICES (JANUARY 2014–DECEMBER 2024)
FIGURE 35
ADJACENT MARKETS TO DIABETES CARE DEVICES MARKET
FIGURE 36
DIABETES CARE DEVICES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 37
IMPACT OF AI/GEN AI ON DIABETES CARE DEVICES MARKET
FIGURE 38
FUNDING AND NUMBER OF DEALS IN DIABETES CARE DEVICES MARKET, 2019–2023 (USD MILLION)
FIGURE 39
GEOGRAPHIC SNAPSHOT OF DIABETES CARE DEVICES MARKET
FIGURE 40
NORTH AMERICA: DIABETES CARE DEVICES MARKET SNAPSHOT
FIGURE 41
ASIA PACIFIC: DIABETES CARE DEVICES MARKET SNAPSHOT
FIGURE 42
REVENUE SHARE ANALYSIS OF KEY PLAYERS IN DIABETES CARE DEVICES MARKET (2020–2024)
FIGURE 43
MARKET SHARE ANALYSIS OF KEY PLAYERS IN DIABETES CARE DEVICES MARKET (2024)
FIGURE 44
DIABETES CARE DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 45
DIABETES CARE DEVICES MARKET: COMPANY FOOTPRINT
FIGURE 46
DIABETES CARE DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 47
EV/EBITDA OF KEY VENDORS
FIGURE 48
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 49
DIABETES CARE DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 50
R&D EXPENDITURE OF KEY PLAYERS IN DIABETES CARE DEVICES MARKET (2022–2024)
FIGURE 51
F. HOFFMAN-LA ROCHE LTD.: COMPANY SNAPSHOT
FIGURE 52
ABBOTT: COMPANY SNAPSHOT
FIGURE 53
DEXCOM, INC.: COMPANY SNAPSHOT
FIGURE 54
MEDTRONIC: COMPANY SNAPSHOT
FIGURE 55
B. BRAUN SE: COMPANY SNAPSHOT
FIGURE 56
EMBECTA CORP.: COMPANY SNAPSHOT
FIGURE 57
NIPRO: COMPANY SNAPSHOT
FIGURE 58
SENSEONICS: COMPANY SNAPSHOT
FIGURE 59
YPSOMED: COMPANY SNAPSHOT
FIGURE 60
I-SENS, INC.: COMPANY SNAPSHOT
FIGURE 61
TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT
FIGURE 62
INSULET CORPORATION: COMPANY SNAPSHOT
FIGURE 63
TERUMO CORPORATION: COMPANY SNAPSHOT
Growth opportunities and latent adjacency in Diabetes Care Devices Market